factually
Index/Topics/P7C3-A20 Human Trials

P7C3-A20 Human Trials

The status of human clinical trials for P7C3-A20, a compound showing promise in preclinical studies for restoring NAD+ homeostasis and reversing severe pathology in animal models.

Fact-Checks

1 result
Jan 29, 2026
Most Viewed

What clinical trials are planned or underway to test P7C3‑A20 or NAD+‑modulating therapies in humans?

P7C3‑A20 has compelling and recent preclinical data showing restoration of NAD+ homeostasis and reversal of severe pathology in multiple animal models, but no human clinical trials of P7C3‑A20 were re...